Tepmetko savings card: as little as $0 a prescription with commercial insurance

How to pay the least

Ask for the cash price

Tepmetko

We didn’t find one.

Ask your pharmacy for Tepmetko’s cash price, and one or two other pharmacies too.
Tepmetko’s savings card works only with insurance from a job or one you bought.

Free from the maker, if you qualify CoverOne Patient Assistance Program. Please include the most recent tax return (e.g., IRS Form 1040) if applying for the Patient Assistance Program. Or call 1-844-826-8371.

See if you qualify

Compare every option

Brand nameTepmetko

Authorized generictepotinib

Regular generictepotinib

What you’d pay

Cash priceAsk the pharmacy

Not soldThere isn’t one

Not soldNone found

Same as Tepmetko?

The original

–

Brand nameThe maker’s card

CoverOne Co-Pay Assistance Program

Savings card from EMD Serono

No insuranceNeeds insuranceNo cash price listed.

Insurance · as little as $0 a prescription

The card takes up to $15,000 a year off your co-pay.

In the maker’s words

“Enrolled patients may be eligible to pay as little as a $0 co-pay for each prescription of TEPMETKO up to a maximum of $15,000 per year…”

From the maker’s offer on coverone.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Tepmetko itself, from the same company, sold without the brand name, and usually for less. For now Tepmetko is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

Non-small cell lung cancer with a MET gene change

What the FDA label says

TEPMETKO is a kinase inhibitor indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) harboring mesenchymal-epithelial transition (MET) exon 14 skipping alterations.

Source: the FDA label for Tepmetko (EMD Serono, Inc.), April 17, 2025. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/tepmetko/